Amgen’s Stock Soars, But Ratings Lag | Durham News

from Durham News Today | 2 Min News | The Daily News Now!

Amgen’s stock soars despite a downgrade—BofA sees its future growth as shaky, while Gilead and Vertex get top marks with solid catalysts and diversified pipelines. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/2e894a937cdc3a3c

Episode metadata supplied by the publisher feed · Published Aug 14, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Amgen’s Stock Soars, But Ratings Lag | Durham News

0:00 2:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Durham News Today | 2 Min News | The Daily News Now!?

This episode is 2 minutes long.

When was this Durham News Today | 2 Min News | The Daily News Now! episode published?

This episode was published on August 14, 2026.

Can I download this Durham News Today | 2 Min News | The Daily News Now! episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!